---
title: "Johnson & Johnson CEO Joaquin Duato Reports Disposal of Common Shares"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274056852.md"
datetime: "2026-01-28T23:08:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274056852.md)
  - [en](https://longbridge.com/en/news/274056852.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274056852.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/274056852.md) | [繁體中文](https://longbridge.com/zh-HK/news/274056852.md)


# Johnson & Johnson CEO Joaquin Duato Reports Disposal of Common Shares

Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson, reported a disposal of common shares of Johnson & Johnson. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000200406-26-000004), on January 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相关股票

- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-CN/quote/IHI.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [Johnson & Johnson (JNJ.US)](https://longbridge.com/zh-CN/quote/JNJ.US.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-CN/quote/XHE.US.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-CN/quote/IXJ.US.md)

## 相关资讯与研究

- [Orser Capital Management LLC Purchases Shares of 5,217 Johnson & Johnson $JNJ](https://longbridge.com/zh-CN/news/280872064.md)
- [Daratumumab becomes first oncology injectable approved for patient administration](https://longbridge.com/zh-CN/news/280990101.md)
- [Nanobiotix Lung Cancer Trial Data Support Re Rating And Key Catalysts](https://longbridge.com/zh-CN/news/281200344.md)
- [J&J’s Darzalex nets first self-administered cancer injectable approval](https://longbridge.com/zh-CN/news/280822205.md)
- [J&J Says DARZALEX SC Granted EU Approval For First Self-Administered Oncology Treatment](https://longbridge.com/zh-CN/news/280792149.md)